Non categorizzato Eli Lilly to buy Point Biopharma for $1.4 billion Ottobre 3, 2023 0 commenti Eli Lilly and Company revealed on Tuesday its acquisition of Point Biopharma Global Inc., with the total deal valued at approximately $1.4 billion, equivalent to $12.50 per share. “We are excite… About the author:
Get involved!
Comments